» Articles » PMID: 36479229

A 3D Co-culture Intestinal Organoid System for Exploring Glucose Metabolism

Overview
Date 2022 Dec 8
PMID 36479229
Authors
Affiliations
Soon will be listed here.
Abstract

Many treatments have been used for glucose metabolism diseases such as type 2 diabetes, and all of those treatments have several advantages as well as limitations. This review introduces a 3D co-culture intestinal organoid system developed from stem cells, which has the special function of simulating human tissues. Recent studies have revealed that the gut is an important site for exploring the interactions among glucose metabolism, gut microbial metabolism, and gut microbiota. Therefore, 3D intestinal organoid systems can be used to imitate the congenital errors of human gut development, drug screening, food transportation and toxicity analysis. The intestinal organoid system construction methods and their progress as compared with traditional 2D culture methods have also been summarised in the manuscript. This paper discusses the research progress in terms of intestinal organoids applicable to glucose metabolism and provides new ideas for developing anti-diabetic drugs with high efficiency and low toxicity.

Citing Articles

Methodology for awakening the potential secondary metabolic capacity in actinomycetes.

Saito S, Arai M Beilstein J Org Chem. 2024; 20:753-766.

PMID: 38633912 PMC: 11022428. DOI: 10.3762/bjoc.20.69.


Advances in Organoid Technology: A Focus on Corneal Limbal Organoids.

Lu C, Le Q Stem Cell Rev Rep. 2024; 20(5):1227-1235.

PMID: 38558362 DOI: 10.1007/s12015-024-10706-6.

References
1.
Langhans S . Three-Dimensional Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol. 2018; 9:6. PMC: 5787088. DOI: 10.3389/fphar.2018.00006. View

2.
Talchai S, Accili D . Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function. Diabetes. 2015; 64(8):2868-79. PMC: 4512230. DOI: 10.2337/db14-1696. View

3.
Zhang Y, Huang S, Zhong W, Chen W, Yao B, Wang X . 3D organoids derived from the small intestine: An emerging tool for drug transport research. Acta Pharm Sin B. 2021; 11(7):1697-1707. PMC: 8343122. DOI: 10.1016/j.apsb.2020.12.002. View

4.
Loomans C, Williams Giuliani N, Balak J, Ringnalda F, van Gurp L, Huch M . Expansion of Adult Human Pancreatic Tissue Yields Organoids Harboring Progenitor Cells with Endocrine Differentiation Potential. Stem Cell Reports. 2018; 10(3):712-724. PMC: 5918840. DOI: 10.1016/j.stemcr.2018.02.005. View

5.
Gilbert M, Pratley R . GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials. Front Endocrinol (Lausanne). 2020; 11:178. PMC: 7145895. DOI: 10.3389/fendo.2020.00178. View